{
  "slug": "ascento-cda",
  "name": "Ascento Cda",
  "description": "Ascento CDA is an AI-powered platform for Biologic Intelligence that transforms routine retinal OCT data into actionable insights for earlier intervention in chronic diseases. It aims to help healthcare organizations detect biologic activity driving deterioration earlier to improve patient prioritization and provide more timely care.",
  "url": "https://optimly.ai/brand/ascento-cda",
  "websiteUrl": "https://ascento-cda.com/",
  "logoUrl": "https://logo.clearbit.com/ascento-cda.com",
  "baiScore": 55,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": null,
  "archetype_status": "active",
  "category": "AI-powered Medical Imaging & Diagnostics Software",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-09-19T02:18:40.049Z",
  "verifiedVitals": {
    "website": "https://ascento-cda.com",
    "category": "Healthcare Technology",
    "what_it_does": "Ascento Cda transforms routine retinal OCT data into actionable Biologic Intelligence using an AI-powered platform to detect and interpret biologic processes that drive disease progression before conventional clinical manifestations become apparent, enabling earlier intervention and improved patient outcomes.",
    "primary_audience": "Healthcare organizations, providers, and payers, including Accountable Care Organizations, Health Providers, and Payers.",
    "core_product": "The AI Powered Platform for Biologic Intelligence, also referred to as the Inflammatory, Immunologic & Cognitive Mapping Platform (IICM™).",
    "parent_ownership": null
  },
  "intentTags": {
    "problemIntents": [
      "Chronic diseases often progress long before symptoms or conventional diagnostics are visible",
      "Limited visibility into individuals experiencing active biologic changes that could benefit from intervention",
      "Care for chronic diseases is often initiated only after significant, measurable disease progression, making it harder and more costly to manage",
      "Healthcare systems need scalable ways to detect early biologic activity driving deterioration",
      "Identifying patients with hidden biologic deterioration before costly complications arise"
    ],
    "solutionIntents": [
      "Transforming routine retinal OCT data into actionable Biologic Intelligence",
      "Identifying patients who are actively progressing for early intervention and prioritized care",
      "Supporting more informed clinical decision-making through biologic insights",
      "Enabling earlier intervention to improve quality measures and reduce downstream healthcare costs",
      "Leveraging existing OCT infrastructure for scalable population health screening",
      "Detecting hidden biologic activity before clinical deterioration becomes apparent",
      "Facilitating personalized intervention strategies based on biologic drivers",
      "Expanding reimbursable clinical workflows with new insights from existing data",
      "Supporting evidence-informed treatment decisions through biologic validation"
    ],
    "evaluationIntents": [
      "Understanding how Ascento's AI platform processes OCT data to derive Biologic Intelligence",
      "Assessing the benefits and value proposition for Accountable Care Organizations, health providers, and payers",
      "Evaluating the platform's scalability and its integration with existing clinical workflows",
      "Reviewing the applicability of the platform across multiple clinical indications (e.g., cognitive decline, diabetes, cardiovascular disease)",
      "Comparing the effectiveness of early biologic detection versus traditional diagnostic methods"
    ]
  },
  "businessProfileClaims": [],
  "timestamp": 1789846215321
}